{
  "@type": "dcat:Dataset",
  "accessLevel": "public",
  "bureauCode": [
    "009:25"
  ],
  "contactPoint": {
    "@type": "vcard:Contact",
    "fn": "NIH",
    "hasEmail": "mailto:info@nih.gov"
  },
  "description": "Blood substitutes have long been sought after, and artificial oxygen\t\t  carriers may soon become a reality. Despite increased safety of allogeneic\t\t  blood in terms of transmission of infectious diseases [1], avoiding allogeneic blood transfusions remains an important\t\t  goal in perioperative and intensive care medicine. This is because allogeneic\t\t  blood transfusions may cause immunosuppression with an increased incidence of\t\t  postoperative infections [2,3] and\t\t  may adversely affect outcome in intensive care [4], and\t\t  thus they remain a public concern [5].",
  "distribution": [
    {
      "@type": "dcat:Distribution",
      "description": "Visit the original government dataset for complete information, documentation, and data access.",
      "downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137238/",
      "mediaType": "text/html",
      "title": "Official Government Data Source"
    }
  ],
  "identifier": "https://healthdata.gov/api/views/6iff-9rfa",
  "issued": "2025-07-14",
  "keyword": [
    "blood-substitutes",
    "hemoglobin-based",
    "nih",
    "oxygen-carriers",
    "transfusion-alternatives"
  ],
  "landingPage": "https://healthdata.gov/d/6iff-9rfa",
  "modified": "2025-09-29",
  "programCode": [
    "009:048"
  ],
  "publisher": {
    "@type": "org:Organization",
    "name": "National Institutes of Health"
  },
  "theme": [
    "NIH"
  ],
  "title": "Blood substitutes"
}